Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy

American Heart Journal

Volumn 134, Issue 5 I, 1997, Pages 889-900

  Sindone, A P ^a   Keogh, A M ^a   Macdonald, P S ^a   McCosker, C J ^a   Kaan, A F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DILATATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; SURVIVAL;

EID: 0030840314     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)80012-9     Document Type: Article

References (47)